Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.

MLA

Clapéron, Audrey, et al. “Hepatic Myofibroblasts Promote the Progression of Human Cholangiocarcinoma through Activation of Epidermal Growth Factor Receptor.” Hepatology (Baltimore, Md.), vol. 58, no. 6, Dec. 2013, pp. 2001–11. EBSCOhost, https://doi.org/10.1002/hep.26585.

APA

Clapéron, A., Mergey, M., Aoudjehane, L., Ho-Bouldoires, T. H. N., Wendum, D., Prignon, A., Merabtene, F., Firrincieli, D., Desbois-Mouthon, C., Scatton, O., Conti, F., Housset, C., & Fouassier, L. (2013). Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor. Hepatology (Baltimore, Md.), 58(6), 2001–2011. https://doi.org/10.1002/hep.26585

Chicago

Clapéron, Audrey, Martine Mergey, Lynda Aoudjehane, Thanh Huong Nguyen Ho-Bouldoires, Dominique Wendum, Aurélie Prignon, Fatiha Merabtene, et al. 2013. “Hepatic Myofibroblasts Promote the Progression of Human Cholangiocarcinoma through Activation of Epidermal Growth Factor Receptor.” Hepatology (Baltimore, Md.) 58 (6): 2001–11. doi:10.1002/hep.26585.